CompuMed, Inc. (CMPD)
OTCMKTS · Delayed Price · Currency is USD
4.390
+0.130 (3.05%)
Jan 23, 2026, 3:56 PM EST
CompuMed Revenue
CompuMed had revenue of $430.00K in the quarter ending March 31, 2012, with 1.42% growth. This brings the company's revenue in the last twelve months to $1.69M, up 0.47% year-over-year. In the fiscal year ending September 30, 2011, CompuMed had annual revenue of $1.68M, down -4.60%.
Revenue (ttm)
1.69M
Revenue Growth
+0.47%
P/S Ratio
3.34
Revenue / Employee
188.22K
Employees
9
Market Cap
5.66M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2011 | 1.68M | -81.00K | -4.60% |
| Sep 30, 2010 | 1.76M | -286.00K | -13.96% |
| Sep 30, 2009 | 2.05M | -105.00K | -4.88% |
| Sep 30, 2008 | 2.15M | -63.00K | -2.84% |
| Sep 30, 2007 | 2.22M | 102.00K | 4.82% |
| Sep 30, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2002 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pharma-Bio Serv | 9.18M |
| CareView Communications | 8.82M |
| DATATRAK International | 6.50M |
| BioRegenx | 1.93M |
| Resilient Healthcare | 1.21M |
| Dogecoin Cash | 721.56K |
| Mitesco | 52.90K |
CompuMed News
- 1 year ago - CompuMed, FireStarter Collaborate to Further Shared Vision of Saving More Lives through Organ Donation and Transplantation - Accesswire
- 2 years ago - CompuMed Expands Cardiology Services to Rural and Regional Hospitals, Revolutionizing Patient Care - Accesswire
- 2 years ago - CompuMed Integrates the Techcyte Digital Pathology Reviewing Platform to Help Increase Transplanted Organs - Accesswire
- 2 years ago - CompuMed Announces Purchase of Shares held by VI Capital and Changes in the Board of Directors - Accesswire
- 2 years ago - CompuMed Announces Approval and Amendment to Reduce Authorized Shares - Accesswire
- 3 years ago - CompuMed CEO Lee Keddie Joins The Alliance National Innovation Leadership Council - Accesswire
- 3 years ago - Compumed, Inc. Announces Fiscal 2022 Annual and Fourth Quarter Results - Accesswire
- 3 years ago - CompuMed, Inc. Announces Fiscal 2022 Third Quarter Results - Accesswire